tiprankstipranks
Trending News
More News >
Towa Pharmaceutical Co Ltd (TWAPF)
OTHER OTC:TWAPF
US Market

Towa Pharmaceutical Co (TWAPF) Income Statement

Compare
1 Followers

Towa Pharmaceutical Co Income Statement

Last quarter (Q4 2025), Towa Pharmaceutical Co's total revenue was ¥65.86B, an increase of 0.81% from the same quarter last year. In Q4, Towa Pharmaceutical Co's net income was ¥4.36B. See Towa Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 259.59B¥ 227.93B¥ 208.86B¥ 165.62B¥ 154.90B
Gross Profit
¥ 94.73B¥ 81.38B¥ 72.71B¥ 70.19B¥ 65.45B
Operating Expenses
¥ 71.49B¥ 63.73B¥ 67.20B¥ 51.65B¥ 45.52B
Depreciation and Amortization
¥ 20.10B¥ 17.89B¥ 19.41B¥ 10.95B¥ 10.43B
EBITDA
¥ 43.34B¥ 35.54B¥ 24.92B¥ 29.49B¥ 30.35B
Operating Income
¥ 23.24B¥ 17.65B¥ 5.51B¥ 18.54B¥ 19.93B
Other Income/Expenses
¥ 3.09B¥ 6.81B¥ -910.00M¥ 3.71B¥ -1.20B
Pretax Income
¥ 26.33B¥ 24.46B¥ 4.61B¥ 22.25B¥ 18.73B
Net Income
¥ 18.99B¥ 16.17B¥ 2.20B¥ 15.91B¥ 13.96B
Per Share Metrics
Basic EPS
¥ 385.70¥ 328.58¥ 44.72¥ 323.35¥ 283.62
Diluted EPS
¥ 385.70¥ 328.58¥ 43.72¥ 316.19¥ 271.93
Weighted Average Shares Outstanding
49.23M 49.22M 49.22M 49.22M 49.21M
Weighted Average Shares Outstanding (Diluted)
49.23M 49.22M 50.34M 50.33M 51.28M
Currency in JPY

Towa Pharmaceutical Co Earnings and Revenue History